Mirae Asset Global Etfs Holdings Ltd. Heron Therapeutics, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 61,761 shares of HRTX stock, worth $108,081. This represents 0.0% of its overall portfolio holdings.
Number of Shares
61,761Holding current value
$108,081% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding HRTX
# of Institutions
190Shares Held
129MCall Options Held
94.7KPut Options Held
148K-
Rubric Capital Management LP New York, NY26.7MShares$46.7 Million2.77% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.62MShares$15.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY8.33MShares$14.6 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA7.6MShares$13.3 Million0.05% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA6.99MShares$12.2 Million58.47% of portfolio
About HERON THERAPEUTICS, INC.
- Ticker HRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 118,774,000
- Market Cap $208M
- Description
- Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...